136 related articles for article (PubMed ID: 8621297)
1. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants.
Yu Y; Waterman FM; Suntharalingam N; Schulsinger A
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):717-25. PubMed ID: 8621297
[TBL] [Abstract][Full Text] [Related]
2. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric and volumetric criteria for selecting a source activity and a source type ((125)I or (103)Pd) in the presence of irregular seed placement in permanent prostate implants.
Wuu CS; Ennis RD; Schiff PB; Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):815-20. PubMed ID: 10837969
[TBL] [Abstract][Full Text] [Related]
5. The impact of edema on planning 125I and 103Pd prostate implants.
Yue N; Dicker AP; Nath R; Waterman FM
Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
Nath S; Chen Z; Yue N; Trumpore S; Peschel R
Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
[TBL] [Abstract][Full Text] [Related]
7. Is there a preferred strength for regularly spaced 125I seeds in inverse-planned prostate implants?
Sloboda RS; Pedersen JE; Halperin R
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):234-44. PubMed ID: 12504058
[TBL] [Abstract][Full Text] [Related]
8. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
10. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
Nath R; Meigooni AS; Melillo A
Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
[TBL] [Abstract][Full Text] [Related]
11. Tumor dose specification of I-125 seed implants.
Wu A; Zwicker RD; Sternick ES
Med Phys; 1985; 12(1):27-31. PubMed ID: 3974522
[TBL] [Abstract][Full Text] [Related]
12. Comparison of seed loading approaches in prostate brachytherapy.
Butler WM; Merrick GS; Lief JH; Dorsey AT
Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
[TBL] [Abstract][Full Text] [Related]
13. Permanent implantation of 125I sources in the prostate: radical limits of simplicity.
McLaughlin PW; Narayana V; Fields MT; Dworzanin ME; Winfield RJ; Roberson PL
Radiology; 1999 Dec; 213(3):839-44. PubMed ID: 10580964
[TBL] [Abstract][Full Text] [Related]
14. Loading technique comparison in permanent 125I prostate implants.
Williams BV; Horton J; Lawyer A; Chapman J
Med Dosim; 1999; 24(4):273-7. PubMed ID: 10643736
[TBL] [Abstract][Full Text] [Related]
15. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
16. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
[TBL] [Abstract][Full Text] [Related]
17. Optimal placement of radioisotopes for permanent prostate implants.
Narayana V; Roberson PL; Winfield RJ; Kessler ML; McLaughlin PW
Radiology; 1996 May; 199(2):457-60. PubMed ID: 8668794
[TBL] [Abstract][Full Text] [Related]
18. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
[TBL] [Abstract][Full Text] [Related]
19. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative dynamic dose optimization in permanent prostate implants.
Lee EK; Zaider M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):854-61. PubMed ID: 12788195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
